Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Outlook Therapeutics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
-
Aspira Women’s Health Inc. to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
-
LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
-
HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
-
Statera Biopharma, Inc. to Participate in the Cantor Virtual Global Healthcare Conference
-
Cantor Fitzgerald Sees No Negative Read-Through to Novan (NOVN) From Verrica CRL
-
Aligos Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
-
Aligos Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
-
INmune Bio, Inc. Announces Participation at Upcoming Investor Conferences
-
INmune Bio, Inc. Announces Participation at Upcoming Investor Conferences
-
Jaguar Animal Health (JAGX) 'Removing The Clouds Of Uncertainty' - Cantor Fitzgerald
-
Mediant Skill in Alexa Enables Shareholders to 'Voice' Their Proxy Votes for the Investments They Hold
-
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
-
Actinium to Present at Four Upcoming Investor Conferences
-
Chinook Therapeutics to Present at Upcoming Investor Conferences
-
Lineage to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021
-
VYNE Therapeutics to Present at the Cantor Fitzgerald Investment Conference
-
Aristea Therapeutics to Present at Upcoming Investor Conferences
-
Lipocine to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference
-
Tiedemann Group and Alvarium Investments Announce Transaction to Form Alvarium Tiedemann Holdings and List on Nasdaq via Business Combination with Cartesian Growth Corporation (GLBL)
-
Tiedemann Group and Alvarium Investments Announce Transaction to Form Alvarium Tiedemann Holdings and List on Nasdaq via Business Combination with Cartesian Growth Corporation
-
PolyPid to Present at Upcoming Cantor Fitzgerald Global Healthcare Conference
-
UPDATE: Cantor Fitzgerald Starts Clarus (CRXT) at Overweight
-
Endurance Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering
-
Sierra Lake Acquisition Corp. Announces Closing of $300 Million Initial Public Offering
-
Archer Begins Trading on the New York Stock Exchange Under the Symbol “ACHR”
-
KOL Due Diligence Drives Prothena Corp (PRTA) PT to $103 at Cantor Fitzgerald
-
Cutera, Inc. to Participate in a Virtual Fireside Chat at the Cantor Fitzgerald Global Healthcare Conference
-
Form 424B3 Cantor Fitzgerald Income
-
Archer Aviation Inc Closes Merger With Atlas Crest (ACIC) to Become Publicly Traded Under Ticker "ACHR"
-
Archer Aviation Announces Closing of Business Combination with Atlas Crest Investment Corp. to Become A Publicly Traded Company
-
Tilray (TLRY) PT Lowered to $18 at Cantor Fitzgerald, Says Overweight
-
Orchid Island Capital Announces September 2021 Monthly Dividend and August 31, 2021 RMBS Portfolio Characteristics
-
Freddie Mac Prices $907 Million Multifamily K-Deal, K-745
-
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - Update
-
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - Update
-
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in Upcoming Investor Conferences
-
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021
-
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021
-
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Vincerx Pharma, Inc (VINC) Announces 3.5M Share Private Placement at $14.50
-
Vincerx Pharma Announces $50 Million Private Placement
-
Aravive to Participate in Fireside Chat at Cantor Fitzgerald Virtual Global Healthcare Conference
-
Form SC 13G StoneBridge Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
Form SC 13G DTRT Health Acquisition Filed by: CANTOR FITZGERALD SECURITIES
-
IPO for SPAC Endurance Acquisition Corp. (ENDC) Opens at $9.89
-
IPO for SPAC Sierra Lake Acquisition Corp. (SIER) Opens at $9.95
-
Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th
-
Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

